Independent fund research. Built on SEC filings.

How we research funds

ETF · Other · Cambria

Cambria Cannabis ETF (TOKE)

Ticker TOKE · Since 2019-07-24 ·

Expense ratio
0.44%$44/yr per $10k
5-yr return
−16.2%annualized
1-yr return
−7.4%as of Dec 2024

Bottom line

Is TOKE a good fund? The bottom line

TOKE is an actively managed other ETF from Cambria.

Its expense ratio is 0.44% — about $44 a year on every $10,000 invested, cheaper than 76% of other funds we track.

It returned −7.4% over one year, −16.2% a year over five years (as of Dec 31, 2024, per its prospectus).

What stands out

  • Low cost: cheaper than 76% of other peers

What to watch

  • 5-year return in the bottom quarter of its category

Updated Nov 19, 2026

What TOKE invests in

The Fund seeks capital appreciation from investments in the global equity markets that have exposure to the broad cannabis industry.

The Fund is an actively managed exchange -traded fund (ETF) that seeks to achieve its investment objective by investing, under normal market conditions, primarily in (1) Cannabis Companies (defined below), and (2) total return swaps intended to provide exposure to Cannabis Companies. Global equity securities that provide broad exposure to the cannabis industry include companies that (i) engage in or support the legal production, cultivation, and/or sale of cannabis, including marijuana and hemp, such as certain agrobusiness, biotechnology, life sciences, pharmaceutical, retail, finance, and real estate companies, (ii) perform lawful research as to the medical and pharmaceutical applications of marijuana and cannabis extracts, including cannabinoids, or (iii) produce and develop devices, goods, and equipment related to the cannabis industry, including hemp and its legal derivatives…

From the fund's prospectus (filed Aug 28, 2025).

TOKE performance

Fund calendar-year total returns, 2020–2024 2020: +2.0%; 2021: −12.8%; 2022: −44.3%; 2023: −9.9%; 2024: −7.4% +2.0% 2020 −12.8% 2021 −44.3% 2022 −9.9% 2023 −7.4% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
TOKE−7.4%−16.2%—
Other median+9.2%+4.9%+5.3%

Source: Fund prospectus, as of Dec 31, 2024

Full TOKE performance history →

What TOKE costs

On a $10,000 investment, TOKE's 0.44% expense ratio costs about $44 a year. The prospectus estimates $746 in total costs over 10 years (assuming 5% annual returns). The median other fund charges 0.95%.

See the full TOKE fee table →

Alternatives to TOKE

More funds like TOKE →

TOKE FAQ

What is the expense ratio of TOKE?
TOKE's expense ratio is 0.44%, which works out to about $44 a year for every $10,000 invested. The prospectus estimates total costs of $746 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is TOKE a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 76% of other peers; 5-year return in the bottom quarter of its category. This is general information, not personalized advice.
What is TOKE's 5-year return?
TOKE returned −16.2% a year over the five years ending Dec 31, 2024. Past performance does not guarantee future results.
Who manages TOKE?
TOKE is offered by Cambria through Cambria ETF Trust.